• Markets
    • icon
  • Companies
EXL · ASX

Elixinol Wellness Ltd (ASX:EXL)

AU$0.003

 -5.0E-4 (-14.286%)
ASX:Live
26/07/2024 02:52:20 PM
HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EXL Overview

EXL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About EXL

Website

Elixinol Wellness Ltd

Telephone

61.2.9161.4275

Address

Level 12 680 George Street Sydney, New South Wales (NSW) 2000

Description

Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.

EXL Price Chart

Key Stats

Market Cap

AU$4.62M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.01

Trade Value (12mth)

AU$2,427.00

1 week

16.67%

1 month

0%

YTD

-65.38%

1 year

-64%

All time high

3.98

Key Fundamentals

EPS 3 yr Growth

-97.900%

EBITDA Margin

N/A

Operating Cashflow

-$6m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

463m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EXL Announcements

Latest Announcements

Date Announcements

12 July 24

Notification of cessation of securities - EXL

×

Notification of cessation of securities - EXL

01 July 24

Company Secretary Appointment/Resignation

×

Company Secretary Appointment/Resignation

03 June 24

Cleansing Notice

×

Cleansing Notice

31 May 24

Notification regarding unquoted securities - EXL

×

Notification regarding unquoted securities - EXL

31 May 24

Application for quotation of securities - EXL

×

Application for quotation of securities - EXL

31 May 24

Application for quotation of securities - EXL

×

Application for quotation of securities - EXL

31 May 24

Appendix 3Y - David Fenlon

×

Appendix 3Y - David Fenlon

31 May 24

Appendix 3Y - Pauline Gately

×

Appendix 3Y - Pauline Gately

31 May 24

Appendix 3Y - Natalie Butler

×

Appendix 3Y - Natalie Butler

30 May 24

Elixinol Launches Interactive Investor Hub

×

Elixinol Launches Interactive Investor Hub

30 May 24

2024 AGM - Chairman's Presentation

×

2024 AGM - Chairman's Presentation

30 May 24

Results of Meeting

×

Results of Meeting

13 May 24

$2.3m Received from Pet Releaf Sale

×

$2.3m Received from Pet Releaf Sale

13 May 24

FY24 Q1 Appendix 4C re-issue

×

FY24 Q1 Appendix 4C re-issue

10 May 24

Becoming a substantial holder

×

Becoming a substantial holder

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 April 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

19 April 24

Application for quotation of securities - EXL

×

Application for quotation of securities - EXL

18 April 24

Results of Meeting

×

Results of Meeting

08 April 24

Application for quotation of securities - EXL

×

Application for quotation of securities - EXL

04 April 24

Becoming a substantial holder

×

Becoming a substantial holder

03 April 24

Date of Annual General Meeting

×

Date of Annual General Meeting

03 April 24

Notification of cessation of securities - EXL

×

Notification of cessation of securities - EXL

03 April 24

Appendix 3Y - Ronald Dufficy

×

Appendix 3Y - Ronald Dufficy

03 April 24

Appendix 3Y - David Fenlon

×

Appendix 3Y - David Fenlon

03 April 24

Appendix 3X - Natalie Butler

×

Appendix 3X - Natalie Butler

EXL Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.05 -0.03 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.05 -0.03 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 90.7 38.3 63.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.04 -0.03 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.05 -0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.8 27.7 55.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -62.8 -122.9 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.06 0.03 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.06 0.03 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.8 -51.7 -45.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 315 316 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 315 316 N/A Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 9 7 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -37.8 -24.4 17.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 9 7 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -6 -3 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 34.7 47.8 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -67.0 -46.3 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 167 146 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -14 -9 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 36.2 34.3 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -151.2 -131.6 N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -16 -10 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.4 35.9 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -167.2 -141.8 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -17 -11 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock -17 -11 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 83.7 37.9 62.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -182.3 -149.8 -48.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -14 -8 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 4 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -14 -8 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.9 42.7 38.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.5 -1.2 -0.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 13 3 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 25 13 11 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -10 -1 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 4 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 19 9 222 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 21 10 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.0 -51.5 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -67.2 -78.4 -37.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -89.2 -115.4 -1.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -52.0 -61.1 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -58.8 -69.3 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -48.6 -53.4 N/A Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -153.5 -130.7 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.7 0.1 N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -52.4 -11.2 -0.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.2 2.7 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.7 2.2 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 64.6 30.8 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -298.4 -237.0 -145.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.6 1.9 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 4.5 5.2 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 1.2 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 14.6 15.3 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.5 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.5 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -183.0 -149.8 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -67.5 -78.4 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -67.2 -78.4 -37.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.5 0.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -89.2 -115.4 -1.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -89.2 -115.4 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 81.2 69.7 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 101.8 195.1 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 183.0 264.8 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 44.4 45.1 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 138.6 219.7 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EXL Shortsell

Frequently Asked Questions

The current share price of Elixinol Wellness Ltd (EXL:ASX) is AU$0.003.
The 52-week high share price for Elixinol Wellness Ltd (EXL:ASX) is AU$0.01.
The 52-week low share price for Elixinol Wellness Ltd (EXL:ASX)? is AU$0.00.
Elixinol Wellness Ltd (EXL:ASX) does not pay a dividend.
Elixinol Wellness Ltd (EXL:ASX) does not pay a dividend.
Elixinol Wellness Ltd (EXL:ASX) has a franking level of 0.0%.
Elixinol Wellness Ltd (EXL:ASX) is classified in the Healthcare.
The current P/E ratio for Elixinol Wellness Ltd (EXL:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.